| RNWBX | TEOIX | RNWBX / TEOIX | |
| Total Expense Ratio | 1.67 | 0.98 | 170% |
| Annual Report Gross Expense Ratio | 1.67 | 1.00 | 167% |
| Fund Existence | 23 years | 6 years | - |
| Gain YTD | 25.534 | 33.501 | 76% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 76.6B | 198M | 38,687% |
| Annual Yield % from dividends | 0.12 | 0.00 | - |
| Returns for 1 year | 19.74 | 33.17 | 60% |
| Returns for 3 years | 45.78 | 52.00 | 88% |
| Returns for 5 years | 19.82 | 6.22 | 319% |
| Returns for 10 years | 89.72 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| WHIAX | 5.94 | N/A | N/A |
| Macquarie High Income Fund Class A | |||
| NIEYX | 19.49 | -0.13 | -0.66% |
| BNY Mellon International Equity Y | |||
| AMTAX | 10.72 | -0.11 | -1.02% |
| AB All Market Real Return A | |||
| SBPLX | 30.89 | -0.36 | -1.15% |
| ClearBridge Dividend Strategy C | |||
| LYFCX | 14.79 | -0.19 | -1.27% |
| AlphaCentric Life Sciences & Hlthcare C | |||